Acadia Sues Three Manufacturers Over Nuplazid Patent Infringement

Acadia Pharmaceuticals has filed three separate patent infringement suits in an attempt to block generic formulations of its only approved drug, Nuplazid (pimavanserin).
Source: Drug Industry Daily